Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
FREQ [NASD]
Frequency Therapeutics, Inc.
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-1.25 Insider Own2.20% Shs Outstand34.12M Perf Week3.48%
Market Cap264.27M Forward P/E- EPS next Y-1.94 Insider Trans-9.46% Shs Float27.89M Perf Month-13.19%
Income-42.00M PEG- EPS next Q-0.51 Inst Own60.10% Short Float20.49% Perf Quarter-27.72%
Sales34.40M P/S7.68 EPS this Y-29.30% Inst Trans2.18% Short Ratio12.19 Perf Half Y-82.04%
Book/sh5.20 P/B1.54 EPS next Y-27.80% ROA-17.80% Target Price- Perf Year-62.02%
Cash/sh5.92 P/C1.36 EPS next 5Y- ROE-23.00% 52W Range7.34 - 58.37 Perf YTD-77.23%
Dividend- P/FCF- EPS past 5Y- ROI-13.30% 52W High-85.88% Beta-
Dividend %- Quick Ratio10.60 Sales past 5Y- Gross Margin- 52W Low12.34% ATR0.51
Employees83 Current Ratio10.60 Sales Q/Q-35.60% Oper. Margin- RSI (14)45.34 Volatility6.27% 6.04%
OptionableYes Debt/Eq0.08 EPS Q/Q-275.20% Profit Margin- Rel Volume0.25 Prev Close8.03
ShortableYes LT Debt/Eq0.08 Earnings- Payout- Avg Volume468.94K Price8.24
Recom2.20 SMA20-0.56% SMA50-8.44% SMA200-64.57% Volume58,034 Change2.62%
Jan-27-21Upgrade JP Morgan Neutral → Overweight $56
Dec-22-20Initiated B. Riley Securities Buy $79
Jul-14-20Initiated Oppenheimer Outperform $36
May-18-20Downgrade JP Morgan Overweight → Neutral $27
Oct-28-19Initiated JP Morgan Overweight $25
Oct-28-19Initiated Goldman Buy $30
Oct-28-19Initiated Cowen Outperform
Aug-02-21 03:05PM  
CLASS ACTION UPDATE for JRVR, FREQ and QFIN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
ACCESSWIRE
02:30PM  
Final Deadline Alert: Frequency Therapeutics, Inc. (FREQ) Class Action and Last Chance for Investors to Actively Participate - Bronstein, Gewirtz & Grossman, LLC
ACCESSWIRE
12:30PM  
SHAREHOLDER ALERT: FREQ RKT QFIN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
ACCESSWIRE
12:30PM  
FINAL DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Frequency Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
11:00AM  
FREQ Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Frequency Therapeutics, Inc. (FREQ) Shareholders of Class Action and Lead Plaintiff Deadline: August 2, 2021
ACCESSWIRE
10:00AM  
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FREQ, RKT and BZ
ACCESSWIRE
09:16AM  
FREQ Final Deadline Today: Rosen, National Trial Lawyers, Encourages Frequency Therapeutics, Inc. Investors to Secure Counsel Before Important August 2 Deadline in Securities Class Action - FREQ
Newsfile
09:09AM  
DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Frequency Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Newsfile
05:50AM  
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of FREQ, RLX and DIDI
ACCESSWIRE
03:27AM  
Frequency Therapeutics (NASDAQ:FREQ) Has Debt But No Earnings; Should You Worry?
Simply Wall St.
Aug-01-21 10:38AM  
FREQUENCY DEADLINE ALERT: Faruqi & Faruqi LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Frequency To Contact Him Directly To Discuss Their Options
GlobeNewswire
06:36AM  
FREQ FINAL DEADLINE: ROSEN, A TOP RANKED FIRM, Encourages Frequency Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline Tomorrow in Securities Class Action - FREQ
Newsfile
Jul-30-21 08:49PM  
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Frequency Therapeutics, Inc. and Encourages Investors to Contact the Firm
Business Wire
07:19PM  
Frequency Therapeutics, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm
GlobeNewswire
07:10PM  
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Frequency Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FREQ
ACCESSWIRE
05:15PM  
FREQ Final Deadline Monday: Rosen, Leading Trial Attorneys, Encourages Frequency Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important August 2 Deadline in Securities Class Action - FREQ
Newsfile
02:57PM  
FREQ LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Frequency Therapeutics, Inc.
Newsfile
01:30PM  
FINAL DEADLINE IMMINENT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Frequency Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
12:40PM  
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of FREQ, OCGN and BLCT
ACCESSWIRE
11:30AM  
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Frequency Therapeutics, Inc. (FREQ)
Business Wire
11:30AM  
CLASS ACTION UPDATE for CCIV, FREQ and RLX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
ACCESSWIRE
11:00AM  
FREQ INVESTOR ALERT: Shareholder Lawsuit Deadline Approaching
ACCESSWIRE
10:00AM  
SHAREHOLDER ALERT: FREQ RLX DIDI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
ACCESSWIRE
10:00AM  
FREQ Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Frequency Therapeutics, Inc. (FREQ) Shareholders of Class Action and Lead Plaintiff Deadline: August 2, 2021
GlobeNewswire
09:30AM  
MONDAY DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Frequency Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Newsfile
09:00AM  
FREQUENCY THERAPEUTICS SHAREHOLDERS: August 2, 2021 Filing Deadline in Class Action - Contact Lieff Cabraser
ACCESSWIRE
05:18AM  
FREQ ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 2, 2021 in the Class Action Filed on Behalf of Frequency Therapeutics, Inc. Limited Shareholders
Newsfile
Jul-29-21 08:47PM  
Frequency Class Action Reminder
Newsfile
05:29PM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Frequency Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 2, 2021 - FREQ
Newsfile
04:02PM  
MONDAY DEADLINE: Investors with Substantial Losses Have Opportunity to Lead the Frequency Therapeutics, Inc. Class Action Lawsuit - FREQ
PR Newswire
01:15PM  
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FREQ, RLX and OTLY
ACCESSWIRE
12:30PM  
FREQ DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Frequency Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Monday Deadline in Securities Class Action FREQ
GlobeNewswire
10:45AM  
Lawsuits Filed Against FREQ, DIDI and OTLY - Jakubowitz Law Pursues Shareholders Claims
ACCESSWIRE
10:00AM  
FREQ Monday Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Frequency Therapeutics, Inc. (FREQ) Shareholders of Class Action and Lead Plaintiff Deadline: August 2, 2021
ACCESSWIRE
09:24AM  
MONDAY DEADLINE REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Frequency Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Newsfile
05:27AM  
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Frequency Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 2, 2021 - (FREQ)
Newsfile
Jul-28-21 08:00PM  
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Frequency, Athira, Full Truck, and Coinbase and Encourages Investors to Contact the Firm
GlobeNewswire
07:25PM  
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Frequency Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FREQ
PR Newswire
07:07PM  
FREQ LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Frequency Therapeutics, Inc.
Newsfile
05:34PM  
Frequency Shareholder Notice
Newsfile
03:16PM  
FREQ ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 2, 2021 in the Class Action Filed on Behalf of Frequency Therapeutics, Inc. Limited Shareholders
Newsfile
01:45PM  
Frequency Therapeutics, Inc. (FREQ) Misstated the Potential of its Hearing Loss Treatment FX-322
ACCESSWIRE
01:35PM  
FINAL DEADLINE IMMINENT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Frequency Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
01:15PM  
FREQ Investor Alert: Shareholder Lawsuit Filed
Newsfile
12:30PM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Frequency Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 2, 2021 - FREQ
Newsfile
11:00AM  
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Frequency Therapeutics, Inc. (FREQ)
PR Newswire
10:00AM  
FREQ Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Frequency Therapeutics, Inc. (FREQ) Shareholders of Class Action and Lead Plaintiff Deadline: August 2, 2021
Newsfile
09:33AM  
DEADLINE NEXT WEEK: Investors with Substantial Losses Have Opportunity to Lead the Frequency Therapeutics, Inc. Class Action Lawsuit - FREQ
Business Wire
09:30AM  
Lawsuits Filed Against SRAC, FREQ and LOTZ - Jakubowitz Law Pursues Shareholders Claims
ACCESSWIRE
09:07AM  
MONDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Frequency Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Newsfile
Jul-27-21 06:24PM  
CLASS ACTION UPDATE for FREQ, PLL and OTLY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
ACCESSWIRE
05:32PM  
Frequency Shareholder Alert
Newsfile
12:45PM  
FREQ LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Frequency Therapeutics, Inc.
Newsfile
11:15AM  
DEADLINE ALERT for SPCE, FREQ, ACRX, and RLX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
GlobeNewswire
11:14AM  
FREQ Stock: Berger Montague Reminds Investors of Upcoming Deadline for Securities Fraud Class Action Against Frequency Therapeutics, Inc. (FREQ); Lead Plaintiff Deadline is August 2, 2021
Newsfile
10:40AM  
LAWSUITS FILED AGAINST JRVR, SPCE and FREQ - Jakubowitz Law Pursues Shareholders Claims
ACCESSWIRE
09:49AM  
INVESTOR ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Frequency Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Newsfile
09:00AM  
FREQUENCY THERAPEUTICS INVESTORS: August 2, 2021 Filing Deadline in Class Action - Contact Lieff Cabraser
ACCESSWIRE
05:40AM  
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FREQ, BZ and DIDI
ACCESSWIRE
12:50AM  
FINAL DEADLINE IMMINENT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Frequency Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
Jul-26-21 09:45PM  
ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages Frequency Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - FREQ
PR Newswire
08:10PM  
UPCOMING DEADLINE: Investors With Substantial Losses Have Opportunity to Lead the Frequency Therapeutics, Inc. Class Action Lawsuit - FREQ
Newsfile
06:58PM  
FREQ ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 2, 2021 in the Class Action Filed on Behalf of Frequency Therapeutics, Inc. Limited Shareholders
Newsfile
05:28PM  
Frequency Deadline Alert
Newsfile
03:48PM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Frequency Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 2, 2021 - FREQ
Newsfile
03:23PM  
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Frequency Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline FREQ
GlobeNewswire
02:12PM  
INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Reminds Investors of a Securities Class Action Against Frequency, Inc. (NASDAQ: FREQ) and August 2 Deadline
GlobeNewswire
01:55PM  
AUGUST 2 DEADLINE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Frequency Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
01:00PM  
DEADLINE ALERT for FREQ, ACRX, RLX, HMPT: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
GlobeNewswire
12:10PM  
CLASS ACTION UPDATE for FREQ, RLX and RCAR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
ACCESSWIRE
11:13AM  
Berger Montague Reminds Investors of Upcoming Deadline for Securities Fraud Class Action Against Frequency Therapeutics, Inc. (FREQ); Lead Plaintiff Deadline is August 2, 2021
Newsfile
09:45AM  
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SPCE, FREQ and RKT
ACCESSWIRE
09:15AM  
FREQ INVESTOR ALERT: Class Action Lawsuit Filed
ACCESSWIRE
09:08AM  
INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Frequency Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Newsfile
05:40AM  
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FREQ, RKT and DIDI
ACCESSWIRE
12:10AM  
INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Frequency Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
Jul-25-21 11:00AM  
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SRAC, JRVR and FREQ
ACCESSWIRE
11:00AM  
FREQ LOSS ALERT: ROSEN, A LEADING INVESOR RIGHTS LAW FIRM, Encourages Frequency Therapeutics, Inc. Investors with LOSSES OVER $100K to Secure Counsel Before Important Deadline in Securities Class Action - FREQ
ACCESSWIRE
10:34AM  
FREQUENCY DEADLINE ALERT: Faruqi & Faruqi LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Frequency To Contact Him Directly To Discuss Their Options
GlobeNewswire
Jul-24-21 08:35PM  
Frequency Deadline Alert
Newsfile
Jul-23-21 08:43PM  
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Frequency Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FREQ
Newsfile
08:32PM  
Frequency Update
Newsfile
03:00PM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Frequency Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 2, 2021 - FREQ
Newsfile
01:30PM  
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Frequency Therapeutics, Inc. (FREQ)
PR Newswire
11:40AM  
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of WPG, FREQ and OCGN
ACCESSWIRE
10:53AM  
Deadline Approaching for Frequency Therapeutics Investors: Berger Montague Reminds Investors of Upcoming Deadline for Securities Fraud Class Action Against Frequency Therapeutics, Inc. (FREQ); Lead Plaintiff Deadline is August 2, 2021
Newsfile
09:30AM  
CLASS ACTION UPDATE for FREQ, RLX and REKR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
ACCESSWIRE
09:19AM  
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Frequency Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Newsfile
09:15AM  
FREQ Investor Alert: Shareholder Class Action Lawsuit Filed
Newsfile
09:00AM  
FREQUENCY THERAPEUTICS SHAREHOLDERS: August 2, 2021 Filing Deadline in Class Action - Contact Lieff Cabraser
ACCESSWIRE
Jul-22-21 09:00PM  
SHAREHOLDER ALERT: FREQ RLX YMM: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
ACCESSWIRE -5.52%
08:30PM  
Frequency Class Action Reminder
Newsfile
12:37PM  
FREQ ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 2, 2021 in the Class Action Filed on Behalf of Frequency Therapeutics, Inc. Limited Shareholders
Newsfile
11:00AM  
FREQ, ACRX & RLX Class Action Reminders and Deadlines: Bronstein, Gewirtz & Grossman LLC
ACCESSWIRE
10:45AM  
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FREQ, RLX and BLCT
ACCESSWIRE
09:33AM  
FREQ ALERT: Investors With Substantial Losses Have Opportunity to Lead the Frequency Therapeutics, Inc. Class Action Lawsuit
Newsfile
09:18AM  
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Frequency Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Newsfile
05:24AM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Frequency Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 2, 2021 - FREQ
Newsfile
Jul-21-21 09:30PM  
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Frequency Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FREQ
ACCESSWIRE
08:29PM  
Frequency Shareholder Notice
Newsfile
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on harnessing the body's innate biology to repair or reverse damage caused by a range of degenerative diseases. Its Progenitor Cell Activation approach, uses combinations of small molecules to activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIa clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. Frequency Therapeutics, Inc. has a licencse and collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322, as well as collaboration and licensing agreements with Massachusetts Eye and Ear, Mass General Brigham, the Massachusetts Institute of Technology, The Scripps Research Institute, and Cambridge Enterprises Limited. The company was incorporated in 2014 and is headquartered in Lexington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lucchino David L.President and CEOJul 01Option Exercise0.616,9054,212428,681Jul 06 04:22 PM
Lucchino David L.President and CEOJun 21Option Exercise0.61113,69069,351421,776Jun 23 08:31 AM
McCubbin QuentinChief Manufacturing OfficerMay 17Buy8.8510,00088,50010,000May 19 04:04 PM
MARCUS JOEL SDirectorMar 25Option Exercise3.3737,116125,081307,116Mar 29 04:37 PM
Lucchino David L.President and CEOMar 01Option Exercise0.619,4165,744317,502Mar 02 08:01 PM
Lucchino David L.President and CEOMar 01Sale50.439,416474,836308,086Mar 02 08:01 PM
Lucchino David L.President and CEOFeb 08Option Exercise0.6116,55410,098324,640Feb 10 04:55 PM
Lucchino David L.President and CEOFeb 08Sale55.0016,554910,470308,086Feb 10 04:55 PM
Lucchino David L.President and CEOFeb 03Option Exercise0.6111,0366,732319,122Feb 05 07:44 AM
Loose Christopher R.Chief Scientific OfficerFeb 03Sale47.192,00094,38021,782Feb 03 05:58 PM
Lucchino David L.President and CEOFeb 03Sale48.7511,036538,005308,086Feb 05 07:44 AM
Lucchino David L.President and CEOFeb 02Option Exercise0.615,5183,366313,604Feb 04 05:44 PM
Lucchino David L.President and CEOFeb 02Sale46.105,518254,360308,086Feb 04 05:44 PM
Loose Christopher R.Chief Scientific OfficerFeb 02Sale45.028,000360,19623,782Feb 03 05:58 PM
Lucchino David L.President and CEOFeb 01Option Exercise0.6133,10220,192341,188Feb 03 06:05 PM
Lucchino David L.President and CEOFeb 01Sale43.0933,1021,426,370308,086Feb 03 06:05 PM
Lucchino David L.President and CEOJan 27Option Exercise0.619,1965,610317,282Jan 28 05:27 PM
Lucchino David L.President and CEOJan 27Sale42.509,196390,830308,086Jan 28 05:27 PM
Loose Christopher R.Chief Scientific OfficerJan 27Sale42.508,000340,00031,782Jan 28 05:24 PM
Lucchino David L.President and CEOJan 06Option Exercise0.6127,58616,827335,672Jan 08 07:08 AM
Lucchino David L.President and CEOJan 06Sale38.5727,5861,063,917308,086Jan 08 07:08 AM
Lucchino David L.President and CEOJan 04Option Exercise0.6118,39011,218342,190Jan 06 04:53 PM
Lucchino David L.President and CEOJan 04Sale33.2134,1041,132,740308,086Jan 06 04:53 PM
MARCUS JOEL SDirectorDec 22Sale33.6120,000672,134270,000Dec 22 06:41 PM
MARCUS JOEL SDirectorDec 21Sale30.3510,000303,521290,000Dec 22 06:41 PM
MARCUS JOEL SDirectorDec 18Sale36.8919,700726,757300,000Dec 22 06:41 PM
Lucchino David L.President and CEODec 17Option Exercise0.611,120683324,920Dec 21 04:51 PM
Lucchino David L.President and CEODec 17Sale42.641,12047,755323,800Dec 21 04:51 PM
Loose Christopher R.Chief Scientific OfficerDec 17Sale40.638,000325,00139,782Dec 17 08:13 PM
Lucchino David L.President and CEODec 16Option Exercise0.6113,5148,244337,314Dec 16 08:01 PM
Loose Christopher R.Chief Scientific OfficerDec 16Sale38.948,000311,48047,782Dec 16 05:15 PM
Lucchino David L.President and CEODec 16Sale40.0013,514540,560323,800Dec 16 08:01 PM
Lucchino David L.President and CEODec 15Option Exercise0.6113,5148,244337,314Dec 16 08:01 PM
Loose Christopher R.Chief Scientific OfficerDec 15Sale37.288,000298,24055,782Dec 16 05:15 PM
Lucchino David L.President and CEODec 15Sale38.4013,514518,890323,800Dec 16 08:01 PM
Lucchino David L.President and CEODec 14Option Exercise0.6113,5148,244337,314Dec 16 08:01 PM
Lucchino David L.President and CEODec 14Sale35.1213,514474,612323,800Dec 16 08:01 PM
Loose Christopher R.Chief Scientific OfficerDec 14Sale35.008,000280,00063,782Dec 16 05:15 PM
Lucchino David L.President and CEODec 09Option Exercise0.6113,5148,244337,314Dec 10 05:25 PM
Lucchino David L.President and CEODec 09Sale32.9313,514444,984323,800Dec 10 05:25 PM
Lucchino David L.President and CEODec 08Option Exercise0.618,8485,397332,648Dec 09 05:21 PM
Lucchino David L.President and CEODec 08Sale31.268,848276,621323,800Dec 09 05:21 PM
Lucchino David L.President and CEODec 07Option Exercise0.614,6662,846328,466Dec 09 05:21 PM
Lucchino David L.President and CEODec 07Sale30.024,666140,065323,800Dec 09 05:21 PM
Lucchino David L.President and CEODec 01Sale27.9315,714438,871323,800Dec 03 04:40 PM
Loose Christopher R.Chief Scientific OfficerNov 09Sale24.008,000192,00071,782Nov 09 04:34 PM
Loose Christopher R.Chief Scientific OfficerNov 05Sale23.008,000184,00079,782Nov 09 04:34 PM
Lucchino David L.President and CEONov 02Sale20.8115,714326,972339,514Nov 03 06:57 PM
Loose Christopher R.Chief Scientific OfficerOct 13Sale22.008,000176,00087,782Oct 14 04:29 PM
Loose Christopher R.Chief Scientific OfficerOct 08Sale21.128,000168,96095,782Oct 08 05:54 PM
Loose Christopher R.Chief Scientific OfficerOct 07Sale20.008,000160,010103,782Oct 08 05:54 PM
Loose Christopher R.Chief Scientific OfficerOct 06Sale19.468,000155,680111,782Oct 08 05:54 PM
Loose Christopher R.Chief Scientific OfficerOct 05Sale18.358,000146,800119,782Oct 05 05:14 PM
Loose Christopher R.Chief Scientific OfficerOct 02Sale18.928,000151,360127,782Oct 05 05:14 PM
Lucchino David L.President and CEOOct 01Sale19.1315,716300,658355,228Oct 05 04:26 PM
Loose Christopher R.Chief Scientific OfficerOct 01Sale18.848,000150,720135,782Oct 05 05:14 PM
Loose Christopher R.Chief Scientific OfficerSep 23Sale21.134,50095,097143,782Sep 25 08:55 AM
Loose Christopher R.Chief Scientific OfficerSep 09Sale18.974,50085,369148,282Sep 10 04:56 PM
Lucchino David L.President and CEOSep 01Sale18.5515,714291,474370,944Sep 03 04:16 PM
Loose Christopher R.Chief Scientific OfficerAug 19Sale22.974,500103,350152,782Aug 20 04:29 PM
Loose Christopher R.Chief Scientific OfficerAug 05Sale21.214,50095,464157,282Aug 06 05:15 PM
open in yahoo | open in reuters | open in marketwatch | open in google
affiliate • advertise • contact • privacy • help
Do not sell my personal information
Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2021 FINVIZ.com. All Rights Reserved.